Medicare's PAMA Problem: Will 2026 Reimbursement Cuts Crush US Diagnostics Innovation?

Medical Device Global Market Access · Apr 5, 2026 · 3m

This episode examines the critical threat facing the U.S. diagnostics industry due to flawed implementation of the Protecting Access to Medicare Act (PAMA). We explore how skewed data collection has led to severe reimbursement cuts, disproportionately impacting smaller, innovative labs. We discuss the 2026 outlook, the looming risk of market consolidation, and how this environment stifles investment in new diagnostic technologies, potentially limiting patient access to care. - What is the Protecting Access to Medicare Act (PAMA) and why is it a threat to US labs? - How do reimbursement cuts…